These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2538939)

  • 41. Neutron capture therapy using a fast neutron beam: clinical considerations and physical aspects.
    Sauerwein W; Ziegler W; Olthoff K; Streffer C; Rassow J; Sack H
    Strahlenther Onkol; 1989; 165(2-3):208-10. PubMed ID: 2494730
    [No Abstract]   [Full Text] [Related]  

  • 42. Head phantom experiment and calculation for NCT using various neutron beams.
    Matsumoto T; Aizawa O
    Strahlenther Onkol; 1989; 165(2-3):98-100. PubMed ID: 2494756
    [No Abstract]   [Full Text] [Related]  

  • 43. A proposed protocol for clinical trials of boron neutron capture therapy in glioblastoma multiforme.
    Dorn RV; Spickard JH; Griebenow ML
    Basic Life Sci; 1989; 50():135-44. PubMed ID: 2546532
    [No Abstract]   [Full Text] [Related]  

  • 44. [Neutron capture therapy in the treatment of glioblastoma multiforme. Initial experience in the Czech Republic].
    Honová H; Safanda M; Petruzelka L; Burian J; Marek M; Rejchrt J; Sus F; Tovarys F; Dbalý V; Honzátko J; Tomandl I; Mares V
    Cas Lek Cesk; 2004; 143(1):44-7. PubMed ID: 15061119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Boron neutron capture therapy for newly diagnosed glioblastoma: a pilot study in Tsukuba.
    Yamamoto T; Nakai K; Tsurubuchi T; Matsuda M; Shirakawa M; Zaboronok A; Endo K; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S25-6. PubMed ID: 19375927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia.
    Tamat SR; Patwardhan A; Moore DE; Kabral A; Bradstock K; Hersey P; Allen BJ
    Strahlenther Onkol; 1989; 165(2-3):145-7. PubMed ID: 2494717
    [No Abstract]   [Full Text] [Related]  

  • 47. Reactor physics design for an epithermal neutron beam at the Power Burst reactor Facility.
    Wheeler FJ; Rushton BL; Parsons DK; Nigg DW
    Strahlenther Onkol; 1989; 165(2-3):69-71. PubMed ID: 2494746
    [No Abstract]   [Full Text] [Related]  

  • 48. Conjugation, purification and characterization of boronated monoclonal antibodies for use in neutron capture therapy.
    Barth RF; Mafune N; Alam F; Adams DM; Soloway AH; Makroglou GE; Oredipe OA; Blue TE; Steplewski Z
    Strahlenther Onkol; 1989; 165(2-3):142-5. PubMed ID: 2494716
    [No Abstract]   [Full Text] [Related]  

  • 49. Fast neutrons for BNCT.
    Wagner FM; Koester L
    Strahlenther Onkol; 1989; 165(2-3):115-7. PubMed ID: 2494712
    [No Abstract]   [Full Text] [Related]  

  • 50. [Radiotherapy of high grade glioma: use of fast neutrons, therapy and enhancement by neutron capture].
    Paquis P; Pignol JP; Breteau N
    Neurochirurgie; 2000 Feb; 46(1):23-33. PubMed ID: 10790640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma-correlation between radiation dose and radiation injury and clinical outcome.
    Kageji T; Nagahiro S; Matsuzaki K; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1446-55. PubMed ID: 16750328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of iron/aluminium/sulphur and aluminium/sulphur/argon filtered neutron beams.
    Perks CA; Harrison KG
    Strahlenther Onkol; 1989; 165(2-3):95-8. PubMed ID: 2494755
    [No Abstract]   [Full Text] [Related]  

  • 53. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
    Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961.
    Vos MJ; Turowski B; Zanella FE; Paquis P; Siefert A; Hideghéty K; Haselsberger K; Grochulla F; Postma TJ; Wittig A; Heimans JJ; Slotman BJ; Vandertop WP; Sauerwein W
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):392-9. PubMed ID: 15667958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perspectives of the clinical BNCT of malignant gliomas in Czechoslovakia.
    Sourek K; Tovarys F
    Strahlenther Onkol; 1989; 165(2-3):247-9. PubMed ID: 2494741
    [No Abstract]   [Full Text] [Related]  

  • 56. The United States BNCT program.
    Robertson JS; Mahoney FJ
    Strahlenther Onkol; 1989; 165(2-3):249-51. PubMed ID: 2494742
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of gadolinium-157 as a neutron capture therapy agent.
    Brugger RM; Shih JA
    Strahlenther Onkol; 1989; 165(2-3):153-6. PubMed ID: 2494719
    [No Abstract]   [Full Text] [Related]  

  • 58. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Boron neutron capture a a new radiotherapy model].
    Hideghéty K; Sauerwwein W; Rassuw J; Sack H
    Orv Hetil; 1998 Mar; 139(12):675-9. PubMed ID: 9555163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Boron chemistry and target cell affinity.
    Soloway AH; Alam F; Barth RF; Bapat BV
    Strahlenther Onkol; 1989; 165(2-3):118-20. PubMed ID: 2494713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.